STOCK TITAN

MiMedx (NASDAQ: MDXG) GC gains PSU shares, withholds some for taxes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

MIMEDX GROUP General Counsel and CAO William Frank Hulse IV received common shares through the vesting of performance stock units at $4.50 per share. A portion of the vested shares was withheld to cover tax obligations, leaving him with 563,440 directly owned shares after these transactions.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hulse William Frank IV

(Last) (First) (Middle)
1775 WEST OAK COMMONS COURT NE

(Street)
MARIETTA GA 30062

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MIMEDX GROUP, INC. [ MDXG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
General Counsel and CAO
3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/10/2026 M 136,364(1) A $4.5 624,900 D
Common Stock 03/10/2026 F 61,460(2) D $4.5 563,440 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents the payout of shares as a result of the vesting of performance stock units (PSUs) for the performance period from January 1, 2023 to December 31, 2025. The PSUs were granted on March 13. 2023.
2. The reported shares were sold in connection with the vesting of performance stock units (PSUs), as required by company policy, with shares withheld for payment of tax liability upon vesting.
Remarks:
/s/William F. Hulse 03/12/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MIMEDX (MDXG) executive William Frank Hulse IV report in this Form 4?

He reported vesting of performance stock units into common stock and related tax withholding. Shares were issued at $4.50 per share, and some were withheld to satisfy tax liabilities required by company policy.

How many MIMEDX (MDXG) shares did Hulse acquire through vesting on this date?

He acquired 136,364 shares of common stock through the vesting of performance stock units. These shares relate to a performance period from January 1, 2023 to December 31, 2025, granted on March 13, 2023.

How many MIMEDX (MDXG) shares were withheld for taxes in this Form 4?

The filing shows 61,460 common shares were disposed of as a tax‑withholding transaction at $4.50 per share. This withholding was required by company policy upon vesting of the performance stock units.

What is Hulse’s MIMEDX (MDXG) share ownership after these transactions?

After the vesting and tax‑withholding transactions, Hulse directly holds 563,440 shares of MIMEDX common stock. This figure reflects his updated direct ownership position following the performance stock unit payout and related tax share withholding.

Were the MIMEDX (MDXG) transactions an open-market buy or sell?

No, the transactions were not open‑market trades. They reflect automatic vesting of performance stock units and required share withholding to pay tax liabilities, rather than discretionary purchases or sales on the market.
Mimedx Group Inc

NASDAQ:MDXG

View MDXG Stock Overview

MDXG Rankings

MDXG Latest News

MDXG Latest SEC Filings

MDXG Stock Data

650.72M
145.88M
Biotechnology
Surgical & Medical Instruments & Apparatus
Link
United States
MARIETTA